Prognostic Value of Myocardial Scar In Ischemic And Non-Ischemic Cardiomyopathy Using Cardiac Magnetic Resonance Imaging
Abstract Purpose is to evaluate the prognostic value of myocardial scar/fibrosis using cardiac magnetic resonance (CMR) in patients with ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy (NICM).Methods; 156 patients with either ICM or NICM underwent CMR with late gadolinium enhancement (LGE) sequences for assessment of left ventricular ejection fraction (EF), detection and quantification of any myocardial scar/fibrosis using three methods; a) manual, b) number of segments involved, c) percentage of scarred myocardium (segment based). Patients were followed up for at least 6 months for any clinical cardiac event.Results: Males were 56% (mean age 61 years), with minimal follow up (FU) of 6 months. Patients were divided into; group I; ICM (58%) and group II; NICM (36%). Clinical presentation was ranging from eventless (10%), chest pain (18%), heart failure (15%), hospitalization (35%), syncope (1%), ventricular tachycardia (<1%) and cardiac arrest (<1%). The scar mass was more in size in group I (17% ± 15) than in group II (8 % ± 13). Direct linear relationship was observed between scar size and event severity (P value < 0.001). Inverted relationship between LVEF and event severity in group I (P value of < 0.001) was detected, however, no significant correlation between LVEF and event severity in group II (P value 0.128).Conclusion: Myocardial scar size is a strong predictor for the clinical outcome in both ICM and NICM. EF is less reliable to predict morbidity in cardiomyopathy patients. Segments dependent methods for quantification of myocardial scar is comparable to the manual LGE quantifications.